Pharmacodynamics: Effects on the Body

dose–response relationship

Think of dialing up the volume on a speaker. At a whisper-quiet setting almost nothing happens; turn the knob a little and the sound grows fast; keep turning past a point and it barely gets louder — it has hit the ceiling. A drug behaves the same way: as you give more of it, the effect usually rises, but not forever. The dose–response relationship is simply the map between how much drug you give and how big the effect you get.

Plotted on ordinary axes the relationship looks like a tilted 'S', and pharmacologists almost always redraw the horizontal axis on a logarithmic scale (each step is a tenfold jump in dose). On that log scale the middle of the curve becomes a clean straight line, which makes two features easy to read off: the dose that gives half the maximal effect (a measure of how little drug you need) and the height of the plateau (a measure of how large an effect the drug can ever reach).

Two curves can therefore differ in two independent ways — how far left they sit (less drug needed) and how high they climb (bigger ceiling). Confusing these two is one of the most common beginner mistakes: a drug can be very 'strong' in the sense of needing a tiny dose yet still produce only a feeble maximal effect, or vice versa. The same logic underlies dosing decisions, comparisons between candidate molecules, and the safety margin between a helpful dose and a harmful one.

One honest caveat: a smooth dose–response curve describes a population or an averaged tissue, not a guarantee for one patient. Individual people vary in absorption, metabolism, receptor numbers and genetics, so the 'same dose' can land at different points on different people's curves. The relationship is a powerful summary, not a fixed law.

Morphine's pain-relief grows steeply with dose at low amounts, then flattens once enough receptors are engaged; pushing the dose past that plateau adds little relief but plenty of side effects.

More drug is not always more effect — the curve plateaus.

The midpoint dose is often labeled ED50 (the dose effective in half of subjects, in vivo) or EC50 (the concentration giving half-maximal effect, in a tissue or assay). They answer related but not identical questions, so the label matters.

Also called
dose–response curve剂量-反应曲线劑量-反應曲線